AAAAAA

   
Results: 1-7 |
Results: 7
TREATMENT OF MYELODYSPLASTIC SYNDROMES IN CHILDHOOD
Authors: LOCATELLI F DESTEFANO P PESSION A PRETE L
Citation: F. Locatelli et al., TREATMENT OF MYELODYSPLASTIC SYNDROMES IN CHILDHOOD, International journal of pediatric hematology/oncology, 3(2), 1996, pp. 95-104
FREQUENCY OF DONOR CYTOTOXIC T-CELL PRECURSORS DOES NOT CORRELATE WITH OCCURRENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE IN CHILDREN TRANSPLANTED USING UNRELATED DONORS
Authors: MONTAGNA D MACCARIO R COMOLI P PRETE L ZECCA M GIRALDI E DAIELLI C MORETTA A DESTEFANO P LOCATELLI F
Citation: D. Montagna et al., FREQUENCY OF DONOR CYTOTOXIC T-CELL PRECURSORS DOES NOT CORRELATE WITH OCCURRENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE IN CHILDREN TRANSPLANTED USING UNRELATED DONORS, Journal of clinical immunology, 16(2), 1996, pp. 107-114
USE OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN CHILDREN GIVEN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE OR CHRONIC LEUKEMIA
Authors: LOCATELLI F PESSION A ZECCA M BONETTI F PRETE L CARRA AM PRETE A MONTAGNA D COMOLI P TAIBI RM PAOLUCCI G
Citation: F. Locatelli et al., USE OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN CHILDREN GIVEN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE OR CHRONIC LEUKEMIA, Bone marrow transplantation, 17(1), 1996, pp. 31-37
RECOMBINANT HUMAN G-CSF-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS FOR 2NDALLOGENEIC TRANSPLANT AFTER BONE-MARROW GRAFT-REJECTION IN CHILDREN
Authors: ZECCA M PEROTTI C MARRADI P MONTAGNA D GIORGIANI G BALTER R PRETE L LOCATELLI F
Citation: M. Zecca et al., RECOMBINANT HUMAN G-CSF-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS FOR 2NDALLOGENEIC TRANSPLANT AFTER BONE-MARROW GRAFT-REJECTION IN CHILDREN, British Journal of Haematology, 92(2), 1996, pp. 432-434
JUVENILE CHRONIC MYELOGENOUS LEUKEMIA - IN-VITRO CHARACTERIZATION BEFORE AND AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: ZECCA M ROSTI V PINTO L COMOLI P CARRA AM PRETE L BONETTI F PEDRAZZOLI P LOCATELLI F CAZZOLA M
Citation: M. Zecca et al., JUVENILE CHRONIC MYELOGENOUS LEUKEMIA - IN-VITRO CHARACTERIZATION BEFORE AND AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Medical and pediatric oncology, 24(3), 1995, pp. 166-170
BUSULFAN, CYCLOPHOSPHAMIDE AND MELPHALAN AS CONDITIONING REGIMEN FOR BONE-MARROW TRANSPLANTATION IN CHILDREN WITH MYELODYSPLASTIC SYNDROMES
Authors: LOCATELLI F PESSION A BONETTI F MASERATI E PRETE L PEDRAZZOLI P ZECCA M PRETE A PAOLUCCI P CAZZOLA M
Citation: F. Locatelli et al., BUSULFAN, CYCLOPHOSPHAMIDE AND MELPHALAN AS CONDITIONING REGIMEN FOR BONE-MARROW TRANSPLANTATION IN CHILDREN WITH MYELODYSPLASTIC SYNDROMES, Leukemia, 8(5), 1994, pp. 844-849
USE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN AFTER BONE-MARROW TRANSPLANTATION IN PEDIATRIC-PATIENTS WITH ACUTE-LEUKEMIA - EFFECT ON ERYTHROID REPOPULATION IN AUTOLOGOUS VERSUS ALLOGENEIC TRANSPLANTS
Authors: LOCATELLI F ZECCA M PEDRAZZOLI P PRETE L QUAGLINI S COMOLI P DESTEFANO P BEGUIN Y DELLACUNA GR SEVERI F CAZZOLA M
Citation: F. Locatelli et al., USE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN AFTER BONE-MARROW TRANSPLANTATION IN PEDIATRIC-PATIENTS WITH ACUTE-LEUKEMIA - EFFECT ON ERYTHROID REPOPULATION IN AUTOLOGOUS VERSUS ALLOGENEIC TRANSPLANTS, Bone marrow transplantation, 13(4), 1994, pp. 403-410
Risultati: 1-7 |